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We report a rare ‘hypomorphic’ C4 allotype detected uring routine screening in controls for the Rogers: 1 epitope. C4B*15 was distinguished by 
having only faint staining when using polyclonal anti-C4 antibody on agarose immunoelectrophoresis (e.g. hypomorphic), having relatively weak 
hemolytic activity but being strongly reactive with monoclonal antibody to Rodgers 1. TaqI restriction fragment length polymorphism (RFLP) 
demonstrated that C4B*15 segregated with 7 kb and 5.4 kb C4 gene fragments and with the haplotype HLA-A.?,C-, 
B5O,BW6,DR7,DQ2,DRS2,SO7C2/1,15). The 5.4-kb fragment was more intense than the 7.0-kb fragment, suggesting duplication of the 5.4-kb 
fragment. This hypomorphic C4 allotype (genotype frequency =0.0088) has diminished expression of C4 epitopes commonly recognized by polyclo- 
nal anti-C4 and may be missed by standard phenotyping methods. 
C4 allotype; Complement; Polymorphism; Restriction fragment length polymorphism; Immunogenetics 
1. INTRODUCTION 
Human C4 protein is synthesized as a single pro-C4 
molecule and secreted into serum as a three-chain pro- 
tein. C4 is normally encoded by one of two loci (C&l or 
C4B) lying within the major histocompatibility complex 
(MHC) between the HLA-B and the HLA-D complex 
on chromosome 6 [l]. C4A and C4B isotypes differ in 
several ways but, with notable exceptions [2], C4A pro- 
teins carry one or more Rodgers epitopes, while C4B 
proteins carry one or more Chido epitopes. 
was incubated with mouse monoclonal anti-Rodgers (MAB anti- 
Rg : 1) antibody in a concentration of 1: 250 at room temperature for 
2 h (kindly provided by C. Giles, London, England). Following 
washing of the membrane (Phosphate-buffered saline (PBS) and 
polyoxyethylenesorbitan monolaurate (Tween 20) incubation with 
goat peroxidase-conjugated anti-mouse IgG (Sigma A: 4416) at a dilu- 
tion of 1: 300, overnight at 4°C was performed. PBS, hydrogen 
peroxide, and 3’ ,3_diaminobenzidine t trahydrochloride (15 ml, 7.5 
ml, 7.5 pug, respectively) were used to develop the peroxidase-stained 
bands of positive allotypes. 
2.3. Western blot 
A rare C4 allotype has been detected which reacted 
strongly with a monoclonal antibody to Rodgers: 1 
(Rg : 1) but was very faint when using polyclonal anti- 
C4. Using a combination of protein and DNA analyses, 
we have characterized both this C4 gene and its protein 
product. 
2. MATERIALS AND METHODS 
2.1. Agarose gel typing of C4 
Human C4 was precipitated from EDTA plasma with goat anti- 
human C4 antibody [4]. The precipitated gel was washed in 0.25 M 
EDTA (pH 7.5) and disintegrated in a sample buffer containing 10% 
2-mercaptoethanol. Samples were run on a 7.5% sodium dodecyl 
sulfate polyacrylamide gel (SDS-PAGE) at 450 V for 2 h as a vertical 
gel and cooled to 10°C. Proteins in the gel were blotted to a nylon 
membrane at 30 V in a 20% methanol solution containing 25 mM 
Tris(hydroxymethyl)aminomethane d192 mM glycine overnight at 
1O’C. The dried membrane was incubated with monoclonal anti- 
Rg : 1 in a 1: 20 concentration for 2 h at room temperature. The mem- 
brane was then washed in PBS with Tween 20 and incubated with 
peroxidase-conjugated goat anti-mouse IgG overnight at 4°C. The 
peroxidase was developed as described above. Using SDS-PAGE, one 
can separate the a-chains of C4A (96 kDa) from C4B (94 kDa). 
Disodium (ethylenedinitrilo) tetraacetic acid (EDTA) plasma was 
subjected to electrophoresis following incubation with carboxypep- 
tidase B and with neuraminidase [3). Goat polyclonal anti-C4 (Atlan- 
tic Antibodies, Scarborough, ME) was then applied to the gel for im- 
munofixation. The pressed gel was stained with Coomassie Blue in 
acetic acid after washing in saline. 
2.4. DNA analysis 
2.2. Anti-Rodgers immunofixation 
Agarose electrophoresis was first performed as described above and 
proteins were then transferred to a nylon membrane. The membrane 
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DNA was isolated from EDTA-treated whole blood using standard 
methodology. DNA was digested with TaqI according to manufac- 
turer’s suggestion, electrophoresed in an 0.8% agarose gel overnight, 
and transferred to a nylon membrane under alkaline conditions. The 
membranes were hybridized with a 32P-radiolabelled 0.6 kb fragment 
of pA T-A, a 5 ‘-end-oriented fragment. With TaqI restriction enzyme 
digestion, C4A genes yield a 7 kb fragment, C4B genes yield 6.0 and 
5.4 kb fragments [3]. A C4A gene deletion on the haplotype HLA- 
A I, BS, Cw7, DR3,DQ,DR/SCOI will characteristically yield a unique 
6.4 kb TaqI fragment, although this C4 deletion is also found on 
other haplotypes. 
2.5. HLA typing 
HLA typing was performed using standard techniques with an- 
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Fig.1. The C4 phenotype of pedigree Ju. The C4 phenotype by im- 
munodiffusion assay demonstrates that the proband (II-l) has the 
faint allotype (C4B*15) which is more clearly seen in the mother’s 
specimen (I-2) but is obscured by C4B*2 in the sibling (U-2). 
tiserum from the NIH serum bank and was compared to a 60-cell 
panel of known specificities. 
2.6. Pedigree Ju 
The proband is a 22-year-old Caucasian male of German ancestry in 
good health. No family history of disease was detected. The extended 
haplotypes are given in table 1. 
3. RESULTS 
3.1. C4 immunoblot in controls 
With the exception of the proband, Rg : l-positive C4 
allotypes were seen only in the acidic C4A region in 114 
controls (frequency of C4B*15 = 0.0088). No reactivi- 
ty of anti-Rg : 1 was found in either of our previously 
reported CCdeficient individuals [5,6]. 
3.2. C4 immunofixation i pedigree Ju 
In the proband (II-l), an allotype which stains very 
faintly using polyclonal anti-C4 antibody can be seen in 
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Fig.2. Immunoblot and SDS-PAGE. (A) Rg : 1 immunoblot: follow- 
ing transfer of proteins to a nylon membrane, anti-Rg : 1 shows the 
C4B*15 allotype in the mother (I-2) and both siblings (II-l, 11-2). (B) 
SDS-PAGE: following immunoprecipitation, washing and reduction, 
C4 a-chains were separated by vertical gel SDS-PAGE electrophoresis 
and Western blotting. The control specimen and the father had a 
single a-chain of 96 kDa which reacted with MAB anti-Rg : 1. The 
mother and both children have two a-chains reactive with anti-Rg : 1, 
confirming the presence of a Rg : l-positive C4B allotype in these in- 
dividuals. The solitary band above the % kDa band in subject II-2 is 
an artifact. 
the C4B region (fig. 1). This band is more easily detected 
in the mother (I-2) and is probably also present in II-2 
as indicated by the width of the C4B*2 precipitin band. 
The hemolytic activity of C4B*15 was greater than 
C4A *3 but clearly less than C4B*I or C4B*2. This rare 
allele segregates with the haplotype HLA-A2 C-B50 
B W6 DR7 DQ2 DR53/SO7C2(1.12) (table 1, fig. 1). 
3.3. Anti-Rg: 1 immunofixation i pedigree Ju 
After immunofixation with anti-Rg : , a strongly 
positive immunoprecipitin band can be seen in in- 
dividuals I-2, II-1 and 11-2, which is slightly slower than 
C4B*2 (fig.2A). This band correlates with the faint 
Table 1 
Class I, II and III haplotypes in pedigree Ju 
HLA Haplotypes 
HLA-A B BW C DR DQ 
Father 
A 1 8 6 I 3 2 
B 28 18 6 - 2 1 
Mother 
c= 2 50 6 - I 2 
D - 44 4 5 4 3 
’ haplotype carrying the C4B duplication 
b parentheses indicate duplication of C4B 
DRW 
52 
_ 
53 
- 
Complotype 
BF/C2/C4A/C4B 
SC01 
SC42 
S07C2(1,15)b 
SC31 
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Fig.3. Taql RFLP. 32P-labelled PAT-A (5’ fragment) C4 probe was 
used to hybridize with DNA. In II-l, the 7.0- and 5.4-kb bands, 
representing fragments of the C4A and C4B genes, respectively, 
should be of equal intensity since the 6.4-kb fragment is a fragment 
of the single C4B gene on a haplotype with a C4A deletion. Note the 
relatively more intense 5.4-kb band in II-l, II-2 and I-2. 
band seen by C4 immunofixation in these same in- 
dividuals (not shown). By Western blotting, again using 
anti-Rg : 1 monoclonal antibody, two immunoprecipitin 
bands are clearly seen in subjects II-l, 11-2, and I-2, 
whereas a single precipitin band was present in the 
father (I-l) and the control (fig.2B). 
3.4. C4 genes in pedigree Ju 
In the DNA from the proband, TaqI restriction en- 
zyme digestion yields of 7.0 kb, 6.4 kb and 5.4 kb frag- 
ment indicating the presence of only one C4A gene (7.0 
kb fragment) (fig.3) since the 6.4-kb (on paternal 
haplotype A) fragment is characteristic of a haplotype 
with one short C4B gene with a C4A deletion. At least 
two C4B genes are present, as indicated by the detection 
of the 6.4-kb and 5.4-kb fragments. The relatively 
greater intensity of the 5.4-kb fragment (C4B fragment) 
as compared to the 7.0-kb fragment (C4A fragment) 
(ratio = 1.58 in proband 11-l or approximately 3 : 1) is 
consistent with the presence of three short C4B genes in 
an individual with C4A*QCJ C4B*Z/C4A*2 B*I,Z5 
complotype. Since maternal haplotype C segregated 
with C4 TaqI fragments of 7.0 and 5.4 kb, these results 
strongly suggest he presence of a C4B gene duplication 
on the maternal haplotype C. 
4. DISCUSSION 
A rare C4 allotype has been detected which is 
characterized by: (1) very faint reactivity with poly- 
clonal anti-C4 antisera on agarose electrophoresis; (2) 
strong reactivity with MAB anti-Rg : 1 antiserum; (3) 
electrophoretic mobility in agarose which is 
characteristic of a C4B allotype but with diminished 
hemolytic activity for a C4B allotype; and (4) segrega- 
tion with an extended haplotype carrying a probable 
C4B gene duplication within the complotype (SO7C2 
[1,151). 
Diminished reactivity of a C4 allotype has been 
reported in a Lebanese pedigree with a SO7C21 com- 
plotype [5] which is similar to the complotype in our 
pedigree. As was true in our case, the protein product 
was very difficult to detect by agarose electrophoresis 
but readily detected using monoclonal antibody to 
Rodgers. C4B*Z5 was only slightly slower than the 
common C4B*2 and may be part of the same com- 
plotype since reported in a Tunisian population by the 
same French group (HLA-BSO, SO7C[2,X] 1) [8]. In ad- 
dition, the analysis of TaqI RFLP of C4 genes by the 
French group and in our laboratory has provided 
evidence of a C4B gene duplication on the haplotype 
which encodes the ‘hypomorphic’ C4 allotype. 
The use of newer analytical tools to study the C4 
system, such as the use of MAB anti-Rg : 1, has con- 
sistently provided evidence of greater complexity but 
has also resulted in a better understanding of C4 [2]. 
For example, C4 allotypes with reversed Rodgers 
/Chid0 antigenicity (i.e. hybrid proteins) are now well 
described [9]. However, there are several questions rais- 
ed by our detection of a Rg : l-positive C4B allotype 
which is ‘hypomorphic’, that is, difficult to detect by 
standard protein electrophoretic methods. Although we 
did not detect any such allotype in our two patients with 
total C4 deficiency, one can ask how common such 
hypomorphic allotype may be and what is the relation- 
ship of hypomorphic alleles with ‘null’ alleles or with 
total C4 deficiency? What is the biologic activity of 
such hypomorphic variants of C4, such as in virus 
neutralization or in immune complex clearance? 
Although C4B*I5 is hemolytically active, there is clear- 
ly less hemolytic activity than in C4B*Z or C4B*2. Are 
other C4 allotypes which lack C4 epitopes (e.g. the C4A 
duplication encoding C4A*2,3 is Rg : 1,-2) [2] func- 
tionally different than other allotypes; are such 
allotypes important in the pathogenesis of diseases 
[lo]? Further functional studies of purified C4 variants 
and characterization of the encoding genes are neces- 
sary to answer such questions. 
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